Clinical Trial Update: Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from Fudan University evaluating whether TROP2-PET and 18F-FDG PET imaging can predict response to an anti-TROP2 antibody-drug conjugate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• anti-TROP2 antibody-drug conjugate

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer ( HER2 Negative) | Phase 2 | Status: RECRUITING